...
首页> 外文期刊>Advanced synthesis & catalysis >Chiral Lewis Base-Catalyzed, Enantioselective Reduction of Unprotected beta-Enamino Esters with Trichlorosilane
【24h】

Chiral Lewis Base-Catalyzed, Enantioselective Reduction of Unprotected beta-Enamino Esters with Trichlorosilane

机译:手性Lewis碱催化的三氯硅烷对未保护的β-烯氨基酯的对映选择性还原

获取原文
获取原文并翻译 | 示例
           

摘要

Catalytic asymmetric reduction of N-unsubstituted beta-enamino esters represents a major challenge for asymmetric catalysis. In this paper, the first organocatalytic system that could be used for the asymmetric hydrosilylation of N-unsubstituted beta-enamino esters has been developed. Using N-tert-butylsulfinyl-L-proline-derived amides and L-pipecolinic acid-derived formamides as catalyst, a broad range of beta-aryl- and beta-alkyl-substituted free beta-amino esters could be prepared with high yields and enantioselectivities. The practicality was illustrated by the gram-scale asymmetric synthesis of ethyl (R)-3-amino-3-phenylpropanoate and isopropyl (S)-3-amino-4-(2,3,5-trifluorophenyl)butanoate. The resulting product can be smoothly transformed to the FDA approved medicines dapoxetine and sitagliptin in a short synthetic route.
机译:N-未取代的β-烯胺酯的催化不对称还原是不对称催化的主要挑战。在本文中,已经开发出了可用于N-未取代的β-烯胺酸酯的不对称氢化硅烷化的第一个有机催化体系。使用N-叔丁基亚磺酰基-L-脯氨酸衍生的酰胺和L-哌啉酸衍生的甲酰胺作为催化剂,可以高产率制备范围广泛的β-芳基和β-烷基取代的游离β-氨基酯。对映选择性。 (R)-3-氨基-3-苯基丙酸乙酯和异丙基(S)-3-氨基-4-(2,3,5-三氟苯基)丁酸的克级不对称合成说明了实用性。所得产品可以通过短合成途径顺利转化为FDA批准的药物达泊西汀和西他列汀。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号